CD133+ lung cancer stem cells can mediate tumorigenesis of lung cancers [28], thus, we further evaluated whether gal-1 could promote CD133+ lung adenocarcinoma growth in vivo. The gene discussed is PROM1; the disease is lung carcinoma.